Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of HLA-DP3-restricted peptides from EBNA1 recognized by CD4(+) T cells.

Cancer research - 15 Dec 2002

Voo Kui Shin, Fu Tihui, Heslop Helen E, Brenner Malcolm K, Rooney Cliona M, Wang Rong-Fu

Abstract excerpt

The EBV-encoded nuclear antigen 1 (EBNA1) is required for the maintenance and replication of the viral episome in EBV-transformed human B-lymphoblastoid cell lines. It is expressed in all EBV-associated tumors, making it a potentially important target for immunotherapy. However, this promise has...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigen Presentation
Share to Burkitt Lymphoma
Share to Clone Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epitopes, T-Lymphocyte

Share to Epstein-Barr Virus Nuclear Antigens

Share to HLA-DP Antigens

Share to HLA-DP beta-Chains

Share to Leukocytes, Mononuclear

Source

Identifiers

PMID: 12499257

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-12499257-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of HLA-DP3-restricted peptides from EBNA1 recognized by CD4(+) T cells.PMID 12499257Read ↗

Identification of a naturally processed HLA-DR-restricted T-helper epitope in Epstein-Barr virus nuclear antigen type 1.Semantic proximity Read ↗

Critical role of EBNA1-specific CD4+ T cells in the control of mouse Burkitt lymphoma in vivoSemantic proximity Read ↗

Human Cd4+ T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1Semantic proximity Read ↗

Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders.Semantic proximity Read ↗

Induction of EBV–Latent Membrane Protein 1–Specific MHC Class II–Restricted T-Cell Responses against Natural Killer Lymphoma CellsSemantic proximity Read ↗

Full-length EBNA1 mRNA-transduced dendritic cells stimulate cytotoxic T lymphocytes recognizing a novel HLA-Cw*0303- and -Cw*0304-restricted epitope on EBNA1-expressing cells.Semantic proximity Read ↗

Epstein‐Barr virus nuclear antigen 1 evades direct immune recognition by CD4<sup>+</sup> T helper cellsSemantic proximity Read ↗

Immune regulation in Epstein-Barr virus-associated diseasesSemantic proximity Read ↗

Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes.Semantic proximity Read ↗

Cytotoxic T Lymphocytes Simultaneously Targeting Multiple Tumor-associated Antigens to Treat EBV Negative LymphomaSemantic proximity Read ↗

Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma.Semantic proximity Read ↗

Evidence for the Presentation of Major Histocompatibility Complex Class I–restricted Epstein-Barr Virus Nuclear Antigen 1 Peptides to CD8+ T LymphocytesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.